According to ChemoCentryx's latest financial reports and stock price the company's current Operating Margin is -404.57%. At the end of 2021 the company had an Operating Margin of -404.58%.
Year | Operating Margin | Change |
---|---|---|
2021 | -404.58% | 394.21% |
2020 | -81.86% | -44.82% |
2019 | -148.36% | 73.13% |
2018 | -85.70% | -495.77% |
2017 | 21.65% | -106.2% |
2016 | -349.48% | |
2013 | -637.19% | -11.68% |
2012 | -721.48% | 5784.99% |
2011 | -12.26% | 38.4% |
2010 | -8.86% | -127.55% |
2009 | 32.15% | -141.23% |
2008 | -77.98% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.